These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 16899584

  • 1. Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production.
    Coll AP, Fassnacht M, Klammer S, Hahner S, Schulte DM, Piper S, Tung YC, Challis BG, Weinstein Y, Allolio B, O'Rahilly S, Beuschlein F.
    J Endocrinol; 2006 Aug; 190(2):515-25. PubMed ID: 16899584
    [Abstract] [Full Text] [Related]

  • 2. Adrenal regeneration in the rat is mediated by mitogenic N-terminal pro-opiomelanocortin peptides generated by changes in precursor processing in the anterior pituitary.
    Estivariz FE, Morano MI, Carino M, Jackson S, Lowry PJ.
    J Endocrinol; 1988 Feb; 116(2):207-16. PubMed ID: 2832502
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bilateral adrenal enucleation-induced changes in adenohypophyseal pro-opiomelanocortin (POMC)-related peptides synthesis and secretion: a comparative study with adrenalectomized rats.
    Perone MJ, Chisari AN, Gómez Dumm CL, Spinedi E, Estivariz FE.
    J Endocrinol Invest; 1997 Apr; 20(4):172-82. PubMed ID: 9211122
    [Abstract] [Full Text] [Related]

  • 7. The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin.
    Coll AP, Challis BG, Yeo GS, Snell K, Piper SJ, Halsall D, Thresher RR, O'Rahilly S.
    Endocrinology; 2004 Oct; 145(10):4721-7. PubMed ID: 15231703
    [Abstract] [Full Text] [Related]

  • 8. Further evidence that N-terminal pro-opiomelanocortin peptides are involved in adrenal mitogenesis.
    Estivariz FE, Carino M, Lowry PJ, Jackson S.
    J Endocrinol; 1988 Feb; 116(2):201-6. PubMed ID: 2832501
    [Abstract] [Full Text] [Related]

  • 9. Loss of agouti-related peptide does not significantly impact the phenotype of murine POMC deficiency.
    Corander MP, Rimmington D, Challis BG, O'Rahilly S, Coll AP.
    Endocrinology; 2011 May; 152(5):1819-28. PubMed ID: 21363936
    [Abstract] [Full Text] [Related]

  • 10. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.
    Mounien L, Do Rego JC, Bizet P, Boutelet I, Gourcerol G, Fournier A, Brabet P, Costentin J, Vaudry H, Jégou S.
    Neuropsychopharmacology; 2009 Jan; 34(2):424-35. PubMed ID: 18536705
    [Abstract] [Full Text] [Related]

  • 11. Altered glucose homeostasis in proopiomelanocortin-null mouse mutants lacking central and peripheral melanocortin.
    Hochgeschwender U, Costa JL, Reed P, Bui S, Brennan MB.
    Endocrinology; 2003 Dec; 144(12):5194-202. PubMed ID: 12970157
    [Abstract] [Full Text] [Related]

  • 12. Adrenalectomy enhances endotoxemia-induced hypophagia: higher activation of corticotrophin-releasing-factor and proopiomelanocortin hypothalamic neurons.
    Rorato R, Castro M, Borges BC, Benedetti M, Germano CM, Antunes-Rodrigues J, Elias LL.
    Horm Behav; 2008 Jun; 54(1):134-42. PubMed ID: 18374921
    [Abstract] [Full Text] [Related]

  • 13. The role of pro-opiomelanocortin in the ACTH-cortisol dissociation of sepsis.
    Téblick A, Vander Perre S, Pauwels L, Derde S, Van Oudenhove T, Langouche L, Van den Berghe G.
    Crit Care; 2021 Feb 16; 25(1):65. PubMed ID: 33593393
    [Abstract] [Full Text] [Related]

  • 14. Orexin expression is regulated by alpha-melanocyte-stimulating hormone.
    López M, Lage R, Tung YC, Challis BG, Varela L, Virtue S, O'Rahilly S, Vidal-Puig A, Diéguez C, Coll AP.
    J Neuroendocrinol; 2007 Sep 16; 19(9):703-7. PubMed ID: 17680885
    [Abstract] [Full Text] [Related]

  • 15. Synthetic modified N-POMC(1-28) controls in vivo proliferation and blocks apoptosis in rat adrenal cortex.
    Torres TE, de Mendonça PO, Lotfi CF.
    Cell Tissue Res; 2010 Aug 16; 341(2):239-50. PubMed ID: 20585806
    [Abstract] [Full Text] [Related]

  • 16. The proliferative effect of synthetic N-POMC(1-28) peptides in rat adrenal cortex: a possible role for cyclin E.
    Mendonça PO, Lotfi CF.
    Mol Cell Endocrinol; 2011 Apr 10; 336(1-2):156-61. PubMed ID: 21167253
    [Abstract] [Full Text] [Related]

  • 17. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin.
    Yaswen L, Diehl N, Brennan MB, Hochgeschwender U.
    Nat Med; 1999 Sep 10; 5(9):1066-70. PubMed ID: 10470087
    [Abstract] [Full Text] [Related]

  • 18. N-POMC1-28 increases cyclin D expression and inhibits P27(kip1) in the adrenal cortex.
    de Mendonca PO, Liria CW, Machini MT, Lotfi CF.
    Mol Cell Endocrinol; 2013 May 22; 371(1-2):166-73. PubMed ID: 23219869
    [Abstract] [Full Text] [Related]

  • 19. Comparative effect of FGF2, synthetic peptides 1-28 N-POMC and ACTH on proliferation in rat adrenal cell primary cultures.
    Mattos GE, Jacysyn JF, Amarante-Mendes GP, Lotfi CF.
    Cell Tissue Res; 2011 Sep 22; 345(3):343-56. PubMed ID: 21866314
    [Abstract] [Full Text] [Related]

  • 20. Obliteration of alpha-melanocyte-stimulating hormone derived from POMC in pituitary and brains of PC2-deficient mice.
    Miller R, Aaron W, Toneff T, Vishnuvardhan D, Beinfeld MC, Hook VY.
    J Neurochem; 2003 Aug 22; 86(3):556-63. PubMed ID: 12859669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.